HELIX BIO RESEARCH GUIDE
Literature checked: 5 October 2026
Semax is a synthetic peptide made from seven amino acids. It has been investigated in neuroscience research, including studies of neurotrophic signalling and experimental cerebral ischaemia. Its sequence is Met–Glu–His–Phe–Pro–Gly–Pro, often abbreviated to MEHFPGP. [1] [4]
Understanding Semax means looking beyond a product name: what is its structure, which experiments have examined it, and what do those experiments actually tell us? This guide answers those questions and explains what to check when reviewing research material and its supporting documentation.
Research context: Helix Bio supplies research materials for laboratory use only, not for human consumption. This article is an educational overview of selected publications, not a treatment guide or a systematic review.
What is the structure of Semax?
Semax combines the four-amino-acid ACTH fragment Met–Glu–His–Phe with the three-amino-acid sequence Pro–Gly–Pro. This explains the research name ACTH(4–7)PGP. Papers also describe it as an ACTH(4–10) analogue; that terminology does not mean it is the complete ACTH hormone. [3] [4]
| Feature | Reference information |
|---|---|
| Peptide length | Seven amino acids: a heptapeptide |
| Sequence | Met–Glu–His–Phe–Pro–Gly–Pro |
| One-letter sequence | MEHFPGP |
| Molecular formula | C37H51N9O10S |
| Molecular weight | 813.9 g/mol for the reference peptide in PubChem |
The formula and molecular weight above describe the reference molecule. They do not establish the salt composition, water content or measured peptide content of an individual product batch. [1] [6]
Conceptual peptide artwork; the sequence above gives Semax’s actual amino-acid order.
What has Semax research investigated?
The studies below use different experimental settings. A result in a cell culture, a result in a rat brain and a result in a clinical population answer different questions, so it helps to read each finding alongside its methods.
Neurotrophic signalling in cultured cells
In a 2001 study, Shadrina and colleagues examined glial cells obtained from newborn rat basal forebrain. They reported changes in messenger RNA for nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) after exposure to Semax. These are molecules involved in neuronal and glial biology. [2]
This experiment investigated gene expression in a defined cell-culture setting. It did not measure concentration, productivity or memory in people.
BDNF and TrkB in the rat hippocampus
Dolotov and colleagues reported in 2006 that Semax affected BDNF-related measures and TrkB signalling in the rat hippocampus. The study also assessed conditioned avoidance behaviour. The authors proposed that the BDNF/TrkB system could help explain the effects observed in their experiment. [3]
This is a specific research finding, rather than evidence that every change in a BDNF marker produces a useful human outcome. The tissue, species and behavioural test all matter when interpreting it.
Gene expression in experimental cerebral ischaemia
Cerebral ischaemia means an inadequate blood supply to the brain. A 2020 study by Filippenkov and colleagues used a rat model involving temporary interruption and restoration of cerebral blood flow. RNA sequencing identified Semax-associated changes in gene-expression patterns, including pathways related to inflammatory processes and neurotransmission. [4]
These findings help researchers investigate possible mechanisms within that model. They do not establish that a research product protects a person’s brain or treats a medical condition.
Published human research
Human studies of Semax have also been published. For example, a 2018 paper by Gusev and colleagues examined 110 people undergoing rehabilitation after ischaemic stroke. The researchers assessed plasma BDNF, motor performance and functional outcomes, and reported improvements associated with Semax and earlier rehabilitation. [5]
The English abstract does not provide enough detail to establish whether allocation was randomised or assessment was blinded. Its stroke-rehabilitation population also cannot be treated as evidence of improved everyday focus in healthy people. Evaluating clinical confidence requires the full methods, appropriate comparisons and the wider evidence base.
How should you interpret the evidence?
When reading a Semax paper, start with the question the researchers actually tested. The following checks make an abstract much easier to assess:
- Model: Was the work performed in isolated cells, animals or people?
- Comparison: What was the control group, and how were groups assigned?
- Outcome: Did the study measure an RNA signal, a protein, a behaviour or a clinical outcome?
- Limitations: How large was the study, how long did it last, and what uncertainty did the authors report?
Words such as “neuroprotective” should be read in the context of a study’s model and endpoint. A proposed mechanism, a biological marker and a demonstrated benefit are different kinds of evidence.
Research findings need to be interpreted alongside their models, methods and limitations.
Semax 5mg and 10mg: what do the amounts mean?
The Helix Bio Semax research product has 5mg and 10mg options. These labels describe nominal amounts per vial. Milligrams measure mass; millilitres measure volume. A vial’s labelled mass is therefore not a liquid volume, a prepared concentration or a recommended dose.
For quantitative laboratory work, check how the supplier defines the stated amount. Gross powder mass, peptide content and chromatographic purity are different measurements: water and salts can contribute to the preparation without being counted in the same way as peptide purity. [6]
What should you check in Semax documentation?
Read the product specification together with the report for the relevant batch. A useful review begins with these details:
- Identity: The named peptide, sequence and any stated chemical modifications or salt form.
- Traceability: Matching batch or lot numbers on the material and supporting report.
- Methods: Which analytical tests were performed and what each result measures.
- Scope: The tests that are reported, the tests that are absent and the limits of any conclusions.
Peptide suppliers use methods such as mass spectrometry and analytical HPLC, with additional tests for attributes such as peptide content, counter-ions or endotoxin when required. These tests answer different questions; a purity percentage alone does not cover every property of a sample. [7]
For a practical explanation, read how to read a peptide Certificate of Analysis. You can also check the Helix Bio COA page for published documents and request the relevant report if your batch is not listed.
Check documentation against the exact material and batch under review. Artwork is illustrative.
Semax: frequently asked questions
Is Semax a peptide?
Yes. Semax is a synthetic heptapeptide, meaning its chain contains seven amino-acid residues. Its sequence is MEHFPGP. [1] [3]
Does laboratory research prove benefits in healthy people?
No. Findings from cell cultures or animal models need to be distinguished from evidence in people. Even a human study must be assessed against its particular population, design and outcomes; the stroke-rehabilitation study discussed above addresses a different question from everyday cognitive performance.
Does a Certificate of Analysis prove clinical effectiveness?
No. A COA records analytical information about the tested material. It is not a clinical trial and does not establish a treatment benefit.
Where can I find storage information?
Start with the handling instructions supplied for the specific material and batch. The Helix Bio storage and stability guide provides general background; it does not replace product-specific instructions.
Sources and further reading
The descriptions below identify the sources used; they are not reproduced paper titles. Research findings refer to the materials and conditions in those publications, not to testing of Helix Bio products.
- PubChem: Semax reference compound, CID 9811102. Structure, molecular formula and molecular weight.
- Shadrina et al. (2001): neurotrophin gene expression in rat glial cultures. Neuroscience Letters. DOI: 10.1016/S0304-3940(01)01994-2.
- Dolotov et al. (2006): BDNF and TrkB in the rat hippocampus. Brain Research. DOI: 10.1016/j.brainres.2006.07.108.
- Filippenkov et al. (2020): transcriptome responses in a rat ischaemia–reperfusion model. Genes. DOI: 10.3390/genes11060681.
- Gusev et al. (2018): Semax and rehabilitation after ischaemic stroke. English abstract of a Russian-language publication. DOI: 10.17116/jnevro20181183261-68.
- Merck/Sigma-Aldrich: peptide sample amount determination. Technical guidance on purity and peptide content.
- GenScript: peptide analytical testing. Technical guidance on analytical methods and additional quality-control tests.